SALIX PHARMACEUTICALS LTD Deferred Tax Liabilities, Net
SALIX PHARMACEUTICALS LTD had Deferred Tax Liabilities, Net of $564.71 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2015-03-02
- 2014-12-31: Deferred Tax Liabilities, Net $564.71M.
- 2014-09-30: Deferred Tax Liabilities, Net $509.80M; Deferred Tax Liabilities, Net as first filed $535.00M.
- 2014-06-30: Deferred Tax Liabilities, Net $509.80M; Deferred Tax Liabilities, Net as first filed $536.50M.
- 2014-03-31: Deferred Tax Liabilities, Net $509.80M; Deferred Tax Liabilities, Net as first filed $533.10M.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2014-12-31 | $564.71M 10-K · filed 2015-03-02 | |
| 2014-09-30 | $509.80M 10-Q/A · filed 2015-03-02 | $535.00M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $509.80M 10-Q/A · filed 2015-03-02 | $536.50M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $509.80M 10-Q/A · filed 2015-03-02 | $533.10M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $105.07M 10-K · filed 2015-03-02 | $105.07M 10-K · filed 2014-02-28 |
| 2012-12-31 | $126.89M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $138.78M 10-K · filed 2013-03-01 | $143.99M 10-K · filed 2012-02-28 |
| 2010-12-31 | $38.20M 10-K · filed 2012-02-28 |